This content is machine translated SGDV Congress 2024: Atopic dermatitis and psoriasis Happy patient, happy doctor? At the AbbVie Symposium as part of the SGDV Congress 2024, Prof. Dr. Curdin Conrad (CHUV Lausanne) and Prof. Dr. Kilian Eyerich (University of Freiburg, Germany) discussed the concept of…
View Post 7 min This content is machine translated Sponsored Content: Inflammatory skin diseases “New horizons” in the treatment of inflammatory skin diseases The field of inflammatory skin diseases is constantly evolving. Updates on current standard treatments, innovative therapy options and artificial intelligence were presented at two accredited live webinars entitled “New Horizons…
View Post 7 min This content is machine translated Interview with Prof. Thomas Kündig (USZ) and Prof. Diego Kyburz (USB) “You have to stop treating psoriasis as just a skin disease”. In Switzerland, psoriasis affects about 1 to 3 percent of the population [1]. About one in three psoriasis patients also suffers from psoriatic arthritis (PsA), a chronic inflammatory systemic disease that…
View Post 5 min This content is machine translated Sponsored Content: Cumulative Life Course Impairment (CLCI) The burden of psoriasis gets under your skin Psoriasis is a complex chronic disease that can go beyond skin lesions and affect various aspects of life. The underlying inflammation, which can lead to a variety of concomitant diseases,…
View Post 5 min This content is machine translated Sponsored Content: Atopic dermatitis: Roadshow 2024 Better standard of care through joint decision-making The first Swiss Atopic Dermatitis (AD) Roadshow took place at the beginning of February 2024. AD expert Prof. Jonathan Silverberg from the George Washington University School of Medicine and Health…
View Post 5 min This content is machine translated SGDV Congress 2023: Psoriasis and atopic dermatitis On the trail with Sherlock Holmes and CSI – Mystery cases solved At the “somewhat different” AbbVie Symposium at this year’s Swiss Dermatology Congress (SGDV Congress) in Lausanne, experts did some excellent detective work: a missing person was found and the mysteriously…
View Post 5 min This content is machine translated medizinonline Long-term data on upadacitinib show a consistent safety profile and no new safety signals [1].
View Post 5 min This content is machine translated Atopic dermatitis Achieving high treatment goals with the Minimal Disease Activity concept Patients with moderate to severe atopic dermatitis suffer from the physical and psychological effects of the disease and yet do not receive adequate treatment with systemic therapies, or often only…
View Post 26 min This content is machine translated CME Atopic Dermatitis State-of-the-Art of Targeted Immunotherapy for Adult Atopic Dermatitis. Basile Darbellay, MD, MD-PhD (Cabinet Dr. Basile Darbellay Orsières) & Prof. Christoph Schlapbach, MD, PhD (Inselspital Bern) Atopic dermatitis is characterized by eczematous skin lesions, severe pruritus, and great heterogeneity… CME-Test
